Yoon Soo Chang

3.2k total citations
132 papers, 2.5k citations indexed

About

Yoon Soo Chang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yoon Soo Chang has authored 132 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 42 papers in Molecular Biology and 37 papers in Oncology. Recurrent topics in Yoon Soo Chang's work include Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Diagnosis and Treatment (17 papers) and RNA modifications and cancer (12 papers). Yoon Soo Chang is often cited by papers focused on Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Diagnosis and Treatment (17 papers) and RNA modifications and cancer (12 papers). Yoon Soo Chang collaborates with scholars based in South Korea, Taiwan and United States. Yoon Soo Chang's co-authors include Eun Young Kim, Arum Kim, Joon Chang, Li Mao, Waun Ki Hong, Ho‐Young Lee, Chul‐Min Ahn, H.C. Shih, Se Kyu Kim and Fadlo R. Khuri and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Applied Physics.

In The Last Decade

Yoon Soo Chang

127 papers receiving 2.5k citations

Peers

Countries citing papers authored by Yoon Soo Chang

Since Specialization

Citations

This map shows the geographic impact of Yoon Soo Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon Soo Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon Soo Chang more than expected).

Fields of papers citing papers by Yoon Soo Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon Soo Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon Soo Chang. The network helps show where Yoon Soo Chang may publish in the future.

Co-authorship network of co-authors of Yoon Soo Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon Soo Chang. A scholar is included among the top collaborators of Yoon Soo Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon Soo Chang. Yoon Soo Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea 2024 ·Thoracic Cancer ·(unknown), Cheol‐Kyu Park, Seung Joon Kim, Chan Kwon Park, Yoon Soo Chang, Chi Young Jung, Sung Yong Lee, Shin Yup Lee, Jeong‐Seon Ryu, Jeong Eun Lee, Kye Young Lee, Tae Won Jang, Seung Hun Jang, Seong Hoon Yoon, Sang Hoon Lee, Chang‐Min Choi, Hyeong Ryul Kim, Yeon Joo Kim	2
2	Usefulness of bronchial washing fluid for detection of EGFR mutations in non-small cell lung cancer 2023 ·Lung Cancer ·(unknown), Seung Hyun Yong, Sang Hoon Lee, (unknown), Hye Ryun Kim, Min Hee Hong, (unknown), (unknown), (unknown), Yoon Soo Chang, Eun Young Kim	2
3	New targeted therapies for non-small cell lung cancer 2023 ·Journal of Korean Medical Association ·Eun Hye Lee, (unknown), (unknown), (unknown), Eun Young Kim, Yoon Soo Chang	1
4	Outstanding Characteristics of Birt–Hogg–Dube Syndrome in Korea 2023 ·Diagnostics ·Hye Jung Park, Yong Jun Choi, Chul Hwan Park, Tae‐Hoon Kim, Sungsoo Lee, (unknown), Kyung‐A Lee, Sang Eun Lee, Moo Suk Park, Song Yee Kim, Yoon Soo Chang, Seok Jeong Lee, Ji Ye Jung, Ji-Ho Lee, Su Hwan Lee, Taehee Kim, Sung‐Ryeol Kim, (unknown), Min Kwang Byun	1
5	Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma 2023 ·Frontiers in Immunology ·Yoon Jin, Eun Young Kim, Yong Jun Choi, (unknown), Min Kyung Park, Yoon Soo Chang	6
6	Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia 2023 ·International Journal of Oncology ·Yoon Soo Chang, Joell J. Gills, Shigeru Kawabata, Masahiro Onozawa, Giusy Della Gatta, Adolfo A. Ferrando, Peter D. Aplan, Phillip A. Dennis	5
7	Early lung carcinogenesis and tumor microenvironment observed by single-cell transcriptome analysis 2021 ·Translational Oncology ·Eun Young Kim, Yoon Jin, Sang Hoon Lee, (unknown), Yong Jun Choi, Duk Hwan Moon, Sungsoo Lee, Yoon Soo Chang	12
8	An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody 2020 ·Biomolecules ·Dae Gyu Kim, (unknown), Nam Hoon Kwon, (unknown), Semi Lim, Eun Joo Kang, Jihye Lee, Woo‐Young Seo, Arum Kim, Yoon Soo Chang, Hyunbo Shim, Sung‐Hoon Kim	0
9	Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor 2018 ·Journal of Cancer ·(unknown), (unknown), Kyung Soo Chung, Song Yee Kim, Ah Young Leem, Joo Han Song, Ji Ye Jung, Moo Suk Park, Yoon Soo Chang, Young Sam Kim, Joon Chang, Eun Young Kim	15
10	Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma 2018 ·BMC Cancer ·Eun Young Kim, Arum Kim, Ga Eun Lee, (unknown), Yoon Soo Chang	11
11	The repeatability of computed tomography lung volume measurements: Comparisons in healthy subjects, patients with obstructive lung disease, and patients with restrictive lung disease 2017 ·PLoS ONE ·(unknown), Tae Hoon Kim, Seokjin Haam, Kyunghwa Han, Min Kwang Byun, Yoon Soo Chang, (unknown), Chul Hwan Park	12
12	ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer 2017 ·Neoplasia ·Eun Young Kim, Ji Ye Jung, Arum Kim, Yoon Soo Chang, Soon Il Kim	21
13	Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer 2017 ·BMC Cancer ·Eun Young Kim, Ji Ye Jung, Arum Kim, Kwangsoo Kim, Yoon Soo Chang	30
14	AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical models 2014 ·Cancer Letters ·Eun Young Kim, Arum Kim, Soon Il Kim, Yoon Soo Chang	16
15	KRAS oncogene substitutions in Korean NSCLC patients: Clinical implication and relationship with pAKT and RalGTPases expression 2014 ·Lung Cancer ·Eun Young Kim, Arum Kim, Se Kyu Kim, Hyung Jung Kim, Joon Chang, (unknown), Jae Seok Lee, Hyo Sup Shim, Yoon Soo Chang	12
16	Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells 2014 ·Respiratory Research ·Eun Young Kim, Arum Kim, (unknown), (unknown), Joon Chang, (unknown), Yoon Soo Chang	27
17	Insulin-like growth factor-1 attenuates cisplatin-induced γH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer 2008 ·Cancer Letters ·Jeong Hee Jeon, Young Sam Kim, Hyung Jung Kim, Joon Chang, (unknown), Yoon Soo Chang	21
18	Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer 2007 ·Lung Cancer ·Yoon Soo Chang, Hyung Jung Kim, Joon Chang, Chul‐Min Ahn, Sung Kyu Kim, Se Kyu Kim	73
19	Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer 2004 ·Oncogene ·Yoon Soo Chang, Luo Wang, Young‐Ah Suh, Li Mao, Saul J. Karpen, Fadlo R. Khuri, Waun Ki Hong, Ho‐Young Lee	57
20	Parasitic Infection in a Psychiatric Institution in Taiwan, With Special Reference to Entamoeba histolytica 1995 ·Shiou-Jeng Ong, Mengyuan Cheng, (unknown), (unknown), L. P. Chow, Tina L. Cheng, (unknown), Yoon Soo Chang, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact